Sign In
CPSI Share                                                                      
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ ​​
Publication Type: Safety Notice
Single or Multiple Incident: Multiple
Date: 9/9/2021 12:00:00 AM
Country: Australia

This safety notice addresses the potential shortage of remdesivir, a nucleotide analogue prodrug that inhibits RNA polymerases. It is used to treat hospitalised patients with moderate to severe COVID-19 who require oxygen but not ventilation. The alert provides inclusion and exclusion criteria as well as clinical recommendations for the judicious use of remdesivir to ensure optimal usage of available stock.

Additional Details

antiviral, remdesivir (Veklury®), oxygen

Remdesivir 100 mg injection – disruption to supply